The Insight Partners published latest research report on “Intradermal Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method, Application, and End User”, the global market size is projected to reach USD 7,415.70 million by 2028 from USD 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.
The Insight Partners published latest research report on “Intradermal Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method, Application, and End User”, the global market size is projected to reach USD 7,415.70 million by 2028 from USD 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00019998
Global Intradermal Injection Market: Competitive Landscape and Key Developments:
Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmaje, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices are among the key companies operating in the intradermal injection market. Leading players focus on product launches to expand and diversify their market presence and acquire a new customer base, thereby tapping prevailing business opportunities.
In November 2021, NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass’s MicronJet 600 intradermal delivery device in the US. The marketing of Micronject 600 is believed to trigger the adoption rate of intradermal injections in the near future.
The report highlights trends prevailing in the market and factors driving the market growth. The intradermal injection market growth is attributed to the increasing intradermal vaccination, increasing incidence of various diseases, and rising acceptance of aesthetic procedures. Additionally, strategic developments by manufacturers are likely to emerge as a significant trend in the market during the forecast period. However, the risks, complications, and dosing limitations associated with intradermal injections market hamper the growth of the intradermal injection market.
Growing Developments in Intradermal Injection Technology Boost Global Intradermal Injection Market Growth:
Over the past two decades, there has been an unprecedented surge in the demand for intradermal injections due to rising incidence of various diseases and increasing acceptance of intradermal vaccination and aesthetic procedures. Moreover, the demand for less invasive intradermal devices such as intradermal jet injectors, microinjections, and ballistic intradermal injections is rising among the population for treatment and diagnostic purposes. As per the data of WHO, tuberculosis is the 13th leading cause of death, and about 10 million cases of TB have been recorded every year, which resulted in the sudden rise in the diagnostic rate of TB during the last decade and acts as one of the leading reason for increasing market size of tuberculin syringes. The number of aesthetic procedures is increasing rapidly in North American and European countries.
Directly Purchase Premium Copy of Intradermal Injection Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPRE00019998
Global Intradermal Injection Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 3,513.26 Million in 2021 |
| Market Size Value by | USD 7,415.70 Million by 2028 |
| Growth rate | CAGR of 11.3% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
| No. of Pages | 197 |
| No. of Tables | 138 |
| No. of Charts & Figures | 77 |
| Historical data available | Yes |
| Segments covered | Method, Application, and End User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 197 pages with 138 list of tables & 77 list of figures from the report, “Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method (Normal Sized Needles, Short Needle {Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices}, and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors}), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/intradermal-injections-market
During the past few years, intradermal injections associated procedures and devices have undergone continuous innovations, and several novel technologies are incorporated in this segment for the advancement of this sector. The vaccination and diagnosis rates related to several complications have increased exponentially during the last decade, ultimately increasing the acceptance of intradermal injections.
North America is expected to hold the largest share of the intradermal injection market during the forecast period. The US is the largest contributor to the regional market, and the market is likely to continue to grow in the coming years due to the increasing diagnostic rates, intradermal vaccination, and cosmetic surgeries, as well as the technological advancements by key players in intradermal injections.
The World Health Organization (WHO) recognizes waste reduction in healthcare delivery as an important aspect of strengthening health systems. Technological advancements have led to the development of surgical approaches that minimize waste and achieve better results with the available resources. The reusable intradermal devices are among the approaches that result in low waste generation, which has a net positive effect on the productivity of an economy. Along with this, the results of several meta-analyses also demonstrated that the intradermal delivery of the drug can reduce the intensity of adverse events as a comparatively low concentration of the drug is required for achieving the optimum responses. The factors mentioned above indicates the favourable condition for the rapid growth of this segment in the future.
Intradermal Injection Market: Segmental Overview
Based on end user, the intradermal injection market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. In 2021, the hospital segment is estimated to hold the largest share of the market, and the market of diagnostic laboratories is expected to grow at the highest CAGR during 2021–2028.
Based on method, the intradermal injection market is segmented into normal-sized needles, short needles, and without needles. The short needles are further sub segmented into intradermal microinjection, microneedle arrays and tattoo devices, while the without needles are sub segmented into intradermal liquid jet injectors, and ballistic intradermal injectors. The normal-sized needles segment dominated the market in 2021, while the short needle segment is expected to witness the highest CAGR from 2021 to 2028. Based on application, the intradermal injection market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment is estimated to hold the largest share of the market in 2021, while the local aesthetic segment is expected to register the highest CAGR during the forecast period. On the basis of end user, the intradermal injection market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment is expected to be the largest shareholder in the market in 2021, while the diagnostic laboratories segment is expected to register the highest CAGR from 2021 to 2028.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Needle Guides Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Microscopic Needle Holder Market Forecast to 2028 - Covid-19 Impact and Global Analysis
Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis
Diagnostic Labs Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Tuberculosis Infection Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/intradermal-injections-market